SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-106525
Filing Date
2021-04-05
Accepted
2021-04-05 17:27:00
Documents
2
Group Members
BRONSON CROUCHCV-IMMETACYTE MANAGER LPCV-IMMETACYTE ULTIMATE MANAGER LLCSB2A LPSB2A MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d162823dsc13d.htm SC 13D 131103
2 EX-99.A d162823dex99a.htm EX-99.A 8966
  Complete submission text file 0001193125-21-106525.txt   141731
Mailing Address 3963 MAPLE AVENUE SUITE 390 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 390 DALLAS TX 75219 972-979-7800
Curative Ventures V LLC (Filed by) CIK: 0001754072 (see all company filings)

IRS No.: 831470127 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Subject) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92439 | Film No.: 21806765
SIC: 2836 Biological Products, (No Diagnostic Substances)